ENHANCEMENT OF SOLUBİLİTY OF POORLY SOLUBLE DRUG LANSOPRAZOLE

Authors

  • SWATI MUTHA School of Pharmacy, Vishwakarma University, Pune, Maharashtra, INDIA
  • VISHAL SHELKE PDEA’s Seth Govind Raghunath Sable College of Pharmacy, Saswad, Department of Pharmaceutics, Tal – Purandar, Dist – Pune, Maharashtra, INDIA
  • KANCHAN GUPTA School of Pharmacy, Vishwakarma University, Pune, Maharashtra, INDIA
  • MRUNALINI KULKARNI School of Pharmacy, Vishwakarma University, Pune, Maharashtra, INDIA
  • AMRITA THAKUR School of Pharmacy, Vishwakarma University, Pune, Maharashtra, INDIA
  • NEETA RAI School of Pharmacy, Vishwakarma University, Pune, Maharashtra, INDIA

Keywords:

Lansoprazole, solubility enhancement, PEG, solid dispersion, Soluplus

Abstract

Objective: To improve the solubility of lansoprazole with solid dispersion (SD) method by using hydrophilic polymer PEG 6000, PEG 15000 and amphiphilic polymer solupus.

Methods: Solid dispersions of lansoprazole were prepared with polymers PEG 6000, PEG 15000 and amphiphilic polymer soluplus, using three methods of preparation – 1) solvent melting 2) solvent evaporation and 3) microwave heating method along with different drug: carrier ratios. Performance of the prepared formulations were evaluated for solubility, fourier transform infrared (FTIR) spectroscopy, and differential scanning calorimetry (DSC) parameters.

Results: All SDs showed enhancement in solubility of lansoprazole. Solubility and also carrier concentration showed positive effect on solubility. The lansoprazole-soluplus solid dispersion 1:3 in concentration showed enhanced aqueous solubility when formulated with solvent melting procedure.

Conclusion: The studies indicated that PEG 6000, PEG 15000 and Soluplus inhibite crystallization of lansoprazole, subsequently form amorphous state in solid dispersion which is confirmed via FTIR and DSC results of lansoprazole solid dispersion.

Downloads

Download data is not yet available.

References

Shelke V, Mutha S. Formulation and evaluation of lansoprazole sublingual tablet. J Res Pharm. Feb 2020 ;24 (2): 264-276.

Garnett WR. Lansoprazole: a proton pump inhibitor. Ann Pharmacother. 1996 Dec; 30 (12) : 1425-36.

Maiden LP, Harris AW. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin. N Engl J Med. 2002 Nov 14;347(20):1623-4; author reply 1623-4. doi: 10.1056/NEJM200211143472016. PMID: 12432054.

Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. Am J Gastroenterol. 2001 Nov;96(11):3089-98. doi: 10.1111/j.1572-0241.2001.05263.x. PMID: 11721754.

Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x. PMID: 11860399.

Tolman KG, Sanders SW, Buchi KN, Karol MD, Jennings DE, Ringham GL. The effects of oral doses of lansoprazole and omeprazole on gastric pH. J Clin Gastroenterol. 1997 Mar;24(2):65-70. doi: 10.1097/00004836-199703000-00003. Erratum in: J Clin Gastroenterol 1998 Apr;26(3):232. PMID: 9077718.

Nikghalb LA, Singh G, Kahkeshan KF. Solid Dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012 Oct; 2(10):170-175.

Bhasin N, Nirmala S. Current trends in solid dispersion:a review. Journal of Drug Delivery & Therapeutics. 2014;4(3):80-86.

Rangarajan.N, Sangeetha.R, Mohanasundaram.S, Sampath.V, Pokodi.K, Dass Prakash MV. Additive inhibitory effect of the peels of Citrus limon and Citrus sinensis against amylase and glucosidase activity. Int. J. Res. Pharm. Sci., 2020;11(4), 6876-6880.

Garg T. An approach for improvement of the water solubility of gliclazide in solid dispersion with PEG 4000. Int J Pharm Sci Res. 2011; 2(6): 1600-02.

Baka E, Comer JE, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008 Jan 22;46(2):335-41. doi: 10.1016/j.jpba.2007.10.030. Epub 2007 Nov 1. PMID: 18055153.

Kavitha R, Sathali AH. Enhancement of solubility of repaglinide by solid dispersion technique. Int J Chem Sci. 2012; 10(1): 377–90.

Neha A, Singh I, Sharma M, Tarun G. An approach for improvement of the water solubility of nimesulide in solid dispersion with peg 4000. IOSR J. Pharm. 2012; 2(2): 153-4.

Nasir AS, Jain AM, Bari MM, Chavan RB, Barhate SD. New dimensions to solid dispersion. Indo Am J Pharm Res. 2013; 3(4): 3246–55.

Lu Y, Guo T, Qi J, Zhang J, Wu W. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling. AAPS PharmSciTech. 2012 Dec;13(4):1222-9. doi: 10.1208/s12249-012-9842-z. Epub 2012 Sep 12. PMID: 22968546; PMCID: PMC3513431.

Patil OA, Patil IS, Mane RU, Randive DS, Bhutkar MA, Bhinge SD. Formulation optimization and evaluation of cefdinir nanosuspension using 23 factorial design. Marmara Pharm J. 2018; 22(4): 587–98.

Published

21-06-2022

How to Cite

MUTHA, S., SHELKE, V., GUPTA, K., KULKARNI, M., THAKUR, A., & RAI, N. (2022). ENHANCEMENT OF SOLUBİLİTY OF POORLY SOLUBLE DRUG LANSOPRAZOLE. International Journal of Applied Pharmaceutics, 14. Retrieved from https://innovareacademics.in/journals/index.php/ijap/article/view/45529

Issue

Section

Original Article(s)

Most read articles by the same author(s)